Search research articles
Contact Us
Filters
Showing results (121-130 of 263) with videos related to
Page
of 27
Sort By:
BMJ Supportive & Palliative Care
|
December 16, 2022
Palliative care symptom management expertise for long-COVID
Rachel Tuffnell, Pippa Sayers, Elena Davis, et al.
Nature Medicine
|
December 13, 2005
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
George V Thomas, Chris Tran, Ingo K Mellinghoff, et al.
American Journal of Clinical Oncology
|
October 8, 2008
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies
Laura W Goff, Mace L Rothenberg, A Craig Lockhart, et al.
Investigative and Clinical Urology
|
January 4, 2022
Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
Nancy Y Greenland, Matthew R Cooperberg, Anthony C Wong, et al.
Cancer Cytopathology
|
August 23, 2025
The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies
Deepika Sirohi, Chien-Kuang Cornelia Ding, Bradley A Stohr, et al.
Virchows Archiv : an International Journal of Pathology
|
January 25, 2025
MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms
Anne V Cheng, Douglas J Wu, Lisa Aviva Friedman, et al.
International Journal of Surgical Pathology
|
April 2, 2024
GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall
Susan K Potterveld, Sean R Williamson, Khaleel I Al-Obaidy, et al.
The Prostate
|
May 12, 2024
Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification
Nancy Y Greenland, Matthew R Cooperberg, Peter R Carroll, et al.
Investigational New Drugs
|
March 30, 2017
Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS
Emily Chan, Laura W Goff, Dana B Cardin, et al.
Histopathology
|
May 13, 2022
An exploration in pitfalls in interpreting SDHB immunohistochemistry
Chien-Kuang Cornelia Ding, Salina Chan, Julie Mak, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 263) with videos related to
Sort By:
Page
of 27
BMJ Supportive & Palliative Care
|
December 16, 2022
Palliative care symptom management expertise for long-COVID
Rachel Tuffnell, Pippa Sayers, Elena Davis, et al.
Nature Medicine
|
December 13, 2005
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
George V Thomas, Chris Tran, Ingo K Mellinghoff, et al.
American Journal of Clinical Oncology
|
October 8, 2008
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies
Laura W Goff, Mace L Rothenberg, A Craig Lockhart, et al.
Investigative and Clinical Urology
|
January 4, 2022
Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
Nancy Y Greenland, Matthew R Cooperberg, Anthony C Wong, et al.
Cancer Cytopathology
|
August 23, 2025
The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies
Deepika Sirohi, Chien-Kuang Cornelia Ding, Bradley A Stohr, et al.
Virchows Archiv : an International Journal of Pathology
|
January 25, 2025
MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms
Anne V Cheng, Douglas J Wu, Lisa Aviva Friedman, et al.
International Journal of Surgical Pathology
|
April 2, 2024
GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall
Susan K Potterveld, Sean R Williamson, Khaleel I Al-Obaidy, et al.
The Prostate
|
May 12, 2024
Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification
Nancy Y Greenland, Matthew R Cooperberg, Peter R Carroll, et al.
Investigational New Drugs
|
March 30, 2017
Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS
Emily Chan, Laura W Goff, Dana B Cardin, et al.
Histopathology
|
May 13, 2022
An exploration in pitfalls in interpreting SDHB immunohistochemistry
Chien-Kuang Cornelia Ding, Salina Chan, Julie Mak, et al.
Page
of 27